{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:11:43Z","timestamp":1770351103395,"version":"3.49.0"},"reference-count":42,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"11","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Acinic cell carcinomas (AcCCs), rare malignancies of the salivary glands, often recur and metastasize, particularly in the skull base. Conventional radical resection can be invasive for skull base AcCCs adjacent to cranial nerves and major vasculature, and the effectiveness of stereotactic radiosurgery (SRS) as an alternative is not well established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>This case report details the application of SRS for recurrent skull base AcCCs. A 71-year-old male with a history of resection for a right mandibular AcCC 23 years earlier experienced tumor recurrence involving the right cavernous sinus and nasal cavity. He underwent endoscopic transnasal surgery followed by SRS targeting different tumor locations\u2014the cavernous sinus to the pterygopalatine fossa, maxillary sinus, and clivus\u2014each with a prescribed dose of 20 Gy to the 40% to 50% isodose line. After the first skull base metastasis, additional sessions of localized SRS after endoscopic surgery led to a 12-year survival without sequela.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>This is a report indicating that SRS for skull base AcCCs can achieve favorable local control, functional preservation, and long-term survival. SRS may be suitable for skull base AcCC given the lesion\u2019s tendency toward multiple local recurrences. Further investigation is needed to validate the treatment\u2019s efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case2476","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T13:00:38Z","timestamp":1710162038000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of stereotactic radiosurgery for recurrent skull base acinic cell carcinoma: illustrative case"],"prefix":"10.3171","volume":"7","author":[{"given":"Tomohiro","family":"Yoshihira","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Umekawa","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shinya","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery"},{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yodai","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[{"name":"Otolaryngology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kondo","sequence":"additional","affiliation":[{"name":"Otolaryngology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuto","family":"Katano","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Shinozaki-Ushiku","sequence":"additional","affiliation":[{"name":"Pathology, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"6","key":"b1","series-title":"J Neurol Surg B Skull Base","first-page":"371","article-title":"Skull base involvement by acinic cell carcinoma of the parotid gland","volume":"73","author":"Breen JT","year":"2012","unstructured":"Breen JT, Carlson ML, Link MJ, Moore EJ, Neff BA, Driscoll CL Skull base involvement by acinic cell carcinoma of the parotid gland. J Neurol Surg B Skull Base. 2012;73(6):371\u2013378."},{"issue":"10","key":"b2","series-title":"Eur Arch Otorhinolaryngol","first-page":"2673","article-title":"Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a literature review","volume":"277","author":"Cavaliere M","year":"2020","unstructured":"Cavaliere M, De Luca P, Scarpa A,  Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a literature review. Eur Arch Otorhinolaryngol. 2020;277(10):2673\u20132679."},{"issue":"11","key":"b3","series-title":"Eur Arch Otorhinolaryngol","first-page":"3511","article-title":"Salivary acinic cell carcinoma: reappraisal and update","volume":"273","author":"Vander Poorten V","year":"2016","unstructured":"Vander Poorten V, Triantafyllou A, Thompson LD,  Salivary acinic cell carcinoma: reappraisal and update. Eur Arch Otorhinolaryngol. 2016;273(11):3511\u20133531."},{"issue":"9","key":"b4","series-title":"ANZ J Surg","first-page":"754","article-title":"Acinic cell carcinoma of the parotid gland: Auckland experience and literature review","volume":"78","author":"Greig SR","year":"2008","unstructured":"Greig SR, Chaplin JM, McIvor NP, Izzard ME, Taylor G, Wee D Acinic cell carcinoma of the parotid gland: Auckland experience and literature review. ANZ J Surg. 2008;78(9):754\u2013758."},{"issue":"4","key":"b5","series-title":"J Otolaryngol","first-page":"262","article-title":"Acinic cell carcinoma of the parotid gland: review and management","volume":"20","author":"Spafford PD","year":"1991","unstructured":"Spafford PD, Mintz DR, Hay J Acinic cell carcinoma of the parotid gland: review and management. J Otolaryngol. 1991;20(4):262\u2013266."},{"key":"b6","series-title":"Head Neck Oncol","first-page":"19","article-title":"Systemic therapy in the management of metastatic or advanced salivary gland cancers","volume":"4","author":"Lagha A","year":"2012","unstructured":"Lagha A, Chraiet N, Ayadi M,  Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head Neck Oncol. 2012;4:19."},{"issue":"1","key":"b7","series-title":"World J Clin Oncol","first-page":"11","article-title":"Predictors of distant metastasis in acinic cell carcinoma of the parotid gland","volume":"11","author":"Ali SA","year":"2020","unstructured":"Ali SA, Kovatch KJ, Yousif J, Gupta S, Rosko AJ, Spector ME Predictors of distant metastasis in acinic cell carcinoma of the parotid gland. World J Clin Oncol. 2020;11(1):11\u201319."},{"issue":"6","key":"b8","series-title":"Laryngoscope Investig Otolaryngol","first-page":"632","article-title":"Outcomes and prognostic factors in parotid gland malignancies: a 10-year single center experience","volume":"4","author":"Parikh AS","year":"2019","unstructured":"Parikh AS, Khawaja A, Puram SV,  Outcomes and prognostic factors in parotid gland malignancies: a 10-year single center experience. Laryngoscope Investig Otolaryngol. 2019;4(6):632\u2013639."},{"issue":"19","key":"b9","series-title":"J Neurosurg Case Lessons","first-page":"CASE23103","article-title":"Stereotactic radiosurgery for recurrent skull base polymorphous adenocarcinoma invading the cavernous sinus: illustrative case","volume":"5","author":"Rai Y","year":"2023","unstructured":"Rai Y, Umekawa M, Shinya Y,  Stereotactic radiosurgery for recurrent skull base polymorphous adenocarcinoma invading the cavernous sinus: illustrative case. J Neurosurg Case Lessons. 2023;5(19):CASE23103."},{"key":"b10","series-title":"Surg Neurol Int","first-page":"509","article-title":"Stereotactic radiosurgery for skull base adenoid cystic carcinoma: A report of two cases","volume":"13","author":"Nakamura Y","year":"2022","unstructured":"Nakamura Y, Umekawa M, Shinya Y,  Stereotactic radiosurgery for skull base adenoid cystic carcinoma: A report of two cases. Surg Neurol Int. 2022;13:509."},{"issue":"4","key":"b11","series-title":"Head Neck","first-page":"492","article-title":"Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy","volume":"30","author":"Douglas JG","year":"2008","unstructured":"Douglas JG, Goodkin R, Laramore GE Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy. Head Neck. 2008;30(4):492\u2013496."},{"issue":"13","key":"b12","series-title":"Cancers (Basel)","first-page":"3373","article-title":"Acinic cell carcinoma in the 21st century: a population-based study from the SEER Database and review of recent molecular genetic advances","volume":"15","author":"Khan J","year":"2023","unstructured":"Khan J, Ullah A, Goodbee M,  Acinic cell carcinoma in the 21st century: a population-based study from the SEER Database and review of recent molecular genetic advances. Cancers (Basel). 2023;15(13):3373."},{"issue":"2","key":"b13","series-title":"Eur Ann Otorhinolaryngol Head Neck Dis","first-page":"111","article-title":"Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy","volume":"129","author":"Buiret G","year":"2012","unstructured":"Buiret G, C\u00e9ruse P, Ramade A, Carrie C, Pommier P Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(2):111\u2013114."},{"issue":"2","key":"b14","series-title":"Int J Radiat Oncol Biol Phys","first-page":"261","article-title":"Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy","volume":"91","author":"McDonald MW","year":"2015","unstructured":"McDonald MW, Linton OR, Calley CS Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy. Int J Radiat Oncol Biol Phys. 2015;91(2):261\u2013267."},{"issue":"3","key":"b15","series-title":"Int J Oral Maxillofac Surg","first-page":"235","article-title":"Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population","volume":"39","author":"Tian Z","year":"2010","unstructured":"Tian Z, Li L, Wang L, Hu Y, Li J Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39(3):235\u2013242."},{"issue":"3","key":"b16","series-title":"Head Neck","first-page":"210","article-title":"Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull","volume":"25","author":"Lee N","year":"2003","unstructured":"Lee N, Millender LE, Larson DA,  Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull. Head Neck. 2003;25(3):210\u2013216."},{"issue":"11","key":"b17","series-title":"Cancer","first-page":"1958","article-title":"Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: a multicenter phase 2 study (Korean Cancer Study Group HN14-01)","volume":"123","author":"Kim Y","year":"2017","unstructured":"Kim Y, Lee SJ, Lee JY,  Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: a multicenter phase 2 study (Korean Cancer Study Group HN14-01). Cancer. 2017;123(11):1958\u20131964."},{"issue":"7","key":"b18","series-title":"Oral Oncol","first-page":"574","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati LD","year":"2009","unstructured":"Locati LD, Bossi P, Perrone F,  Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study. Oral Oncol. 2009;45(7):574\u2013578."},{"issue":"3","key":"b19","series-title":"J Clin Med","first-page":"720","article-title":"Targeted therapy, chemotherapy, immunotherapy and novel treatment options for different subtypes of salivary gland cancer","volume":"11","author":"Mueller SK","year":"2022","unstructured":"Mueller SK, Haderlein M, Lettmaier S,  Targeted therapy, chemotherapy, immunotherapy and novel treatment options for different subtypes of salivary gland cancer. J Clin Med. 2022;11(3):720."},{"issue":"9","key":"b20","series-title":"Oral Oncol","first-page":"822","article-title":"The PI3K\/AKT\/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation","volume":"48","author":"Ettl T","year":"2012","unstructured":"Ettl T, Schwarz-Furlan S, Haubner F,  The PI3K\/AKT\/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation. Oral Oncol. 2012;48(9):822\u2013830."},{"issue":"1","key":"b21","series-title":"Nat Commun","first-page":"368","article-title":"Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands","volume":"10","author":"Haller F","year":"2019","unstructured":"Haller F, Bieg M, Will R,  Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun. 2019;10(1):368."},{"issue":"6","key":"b1","series-title":"J Neurol Surg B Skull Base","first-page":"371","article-title":"Skull base involvement by acinic cell carcinoma of the parotid gland","volume":"73","author":"Breen JT","year":"2012","unstructured":"Breen JT, Carlson ML, Link MJ, Moore EJ, Neff BA, Driscoll CL Skull base involvement by acinic cell carcinoma of the parotid gland. J Neurol Surg B Skull Base. 2012;73(6):371\u2013378."},{"issue":"10","key":"b2","series-title":"Eur Arch Otorhinolaryngol","first-page":"2673","article-title":"Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a literature review","volume":"277","author":"Cavaliere M","year":"2020","unstructured":"Cavaliere M, De Luca P, Scarpa A,  Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a literature review. Eur Arch Otorhinolaryngol. 2020;277(10):2673\u20132679."},{"issue":"11","key":"b3","series-title":"Eur Arch Otorhinolaryngol","first-page":"3511","article-title":"Salivary acinic cell carcinoma: reappraisal and update","volume":"273","author":"Vander Poorten V","year":"2016","unstructured":"Vander Poorten V, Triantafyllou A, Thompson LD,  Salivary acinic cell carcinoma: reappraisal and update. Eur Arch Otorhinolaryngol. 2016;273(11):3511\u20133531."},{"issue":"9","key":"b4","series-title":"ANZ J Surg","first-page":"754","article-title":"Acinic cell carcinoma of the parotid gland: Auckland experience and literature review","volume":"78","author":"Greig SR","year":"2008","unstructured":"Greig SR, Chaplin JM, McIvor NP, Izzard ME, Taylor G, Wee D Acinic cell carcinoma of the parotid gland: Auckland experience and literature review. ANZ J Surg. 2008;78(9):754\u2013758."},{"issue":"4","key":"b5","series-title":"J Otolaryngol","first-page":"262","article-title":"Acinic cell carcinoma of the parotid gland: review and management","volume":"20","author":"Spafford PD","year":"1991","unstructured":"Spafford PD, Mintz DR, Hay J Acinic cell carcinoma of the parotid gland: review and management. J Otolaryngol. 1991;20(4):262\u2013266."},{"key":"b6","series-title":"Head Neck Oncol","first-page":"19","article-title":"Systemic therapy in the management of metastatic or advanced salivary gland cancers","volume":"4","author":"Lagha A","year":"2012","unstructured":"Lagha A, Chraiet N, Ayadi M,  Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head Neck Oncol. 2012;4:19."},{"issue":"1","key":"b7","series-title":"World J Clin Oncol","first-page":"11","article-title":"Predictors of distant metastasis in acinic cell carcinoma of the parotid gland","volume":"11","author":"Ali SA","year":"2020","unstructured":"Ali SA, Kovatch KJ, Yousif J, Gupta S, Rosko AJ, Spector ME Predictors of distant metastasis in acinic cell carcinoma of the parotid gland. World J Clin Oncol. 2020;11(1):11\u201319."},{"issue":"6","key":"b8","series-title":"Laryngoscope Investig Otolaryngol","first-page":"632","article-title":"Outcomes and prognostic factors in parotid gland malignancies: a 10-year single center experience","volume":"4","author":"Parikh AS","year":"2019","unstructured":"Parikh AS, Khawaja A, Puram SV,  Outcomes and prognostic factors in parotid gland malignancies: a 10-year single center experience. Laryngoscope Investig Otolaryngol. 2019;4(6):632\u2013639."},{"issue":"19","key":"b9","series-title":"J Neurosurg Case Lessons","first-page":"CASE23103","article-title":"Stereotactic radiosurgery for recurrent skull base polymorphous adenocarcinoma invading the cavernous sinus: illustrative case","volume":"5","author":"Rai Y","year":"2023","unstructured":"Rai Y, Umekawa M, Shinya Y,  Stereotactic radiosurgery for recurrent skull base polymorphous adenocarcinoma invading the cavernous sinus: illustrative case. J Neurosurg Case Lessons. 2023;5(19):CASE23103."},{"key":"b10","series-title":"Surg Neurol Int","first-page":"509","article-title":"Stereotactic radiosurgery for skull base adenoid cystic carcinoma: A report of two cases","volume":"13","author":"Nakamura Y","year":"2022","unstructured":"Nakamura Y, Umekawa M, Shinya Y,  Stereotactic radiosurgery for skull base adenoid cystic carcinoma: A report of two cases. Surg Neurol Int. 2022;13:509."},{"issue":"4","key":"b11","series-title":"Head Neck","first-page":"492","article-title":"Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy","volume":"30","author":"Douglas JG","year":"2008","unstructured":"Douglas JG, Goodkin R, Laramore GE Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy. Head Neck. 2008;30(4):492\u2013496."},{"issue":"13","key":"b12","series-title":"Cancers (Basel)","first-page":"3373","article-title":"Acinic cell carcinoma in the 21st century: a population-based study from the SEER Database and review of recent molecular genetic advances","volume":"15","author":"Khan J","year":"2023","unstructured":"Khan J, Ullah A, Goodbee M,  Acinic cell carcinoma in the 21st century: a population-based study from the SEER Database and review of recent molecular genetic advances. Cancers (Basel). 2023;15(13):3373."},{"issue":"2","key":"b13","series-title":"Eur Ann Otorhinolaryngol Head Neck Dis","first-page":"111","article-title":"Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy","volume":"129","author":"Buiret G","year":"2012","unstructured":"Buiret G, C\u00e9ruse P, Ramade A, Carrie C, Pommier P Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(2):111\u2013114."},{"issue":"2","key":"b14","series-title":"Int J Radiat Oncol Biol Phys","first-page":"261","article-title":"Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy","volume":"91","author":"McDonald MW","year":"2015","unstructured":"McDonald MW, Linton OR, Calley CS Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy. Int J Radiat Oncol Biol Phys. 2015;91(2):261\u2013267."},{"issue":"3","key":"b15","series-title":"Int J Oral Maxillofac Surg","first-page":"235","article-title":"Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population","volume":"39","author":"Tian Z","year":"2010","unstructured":"Tian Z, Li L, Wang L, Hu Y, Li J Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39(3):235\u2013242."},{"issue":"3","key":"b16","series-title":"Head Neck","first-page":"210","article-title":"Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull","volume":"25","author":"Lee N","year":"2003","unstructured":"Lee N, Millender LE, Larson DA,  Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull. Head Neck. 2003;25(3):210\u2013216."},{"issue":"11","key":"b17","series-title":"Cancer","first-page":"1958","article-title":"Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: a multicenter phase 2 study (Korean Cancer Study Group HN14-01)","volume":"123","author":"Kim Y","year":"2017","unstructured":"Kim Y, Lee SJ, Lee JY,  Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: a multicenter phase 2 study (Korean Cancer Study Group HN14-01). Cancer. 2017;123(11):1958\u20131964."},{"issue":"7","key":"b18","series-title":"Oral Oncol","first-page":"574","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati LD","year":"2009","unstructured":"Locati LD, Bossi P, Perrone F,  Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study. Oral Oncol. 2009;45(7):574\u2013578."},{"issue":"3","key":"b19","series-title":"J Clin Med","first-page":"720","article-title":"Targeted therapy, chemotherapy, immunotherapy and novel treatment options for different subtypes of salivary gland cancer","volume":"11","author":"Mueller SK","year":"2022","unstructured":"Mueller SK, Haderlein M, Lettmaier S,  Targeted therapy, chemotherapy, immunotherapy and novel treatment options for different subtypes of salivary gland cancer. J Clin Med. 2022;11(3):720."},{"issue":"9","key":"b20","series-title":"Oral Oncol","first-page":"822","article-title":"The PI3K\/AKT\/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation","volume":"48","author":"Ettl T","year":"2012","unstructured":"Ettl T, Schwarz-Furlan S, Haubner F,  The PI3K\/AKT\/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation. Oral Oncol. 2012;48(9):822\u2013830."},{"issue":"1","key":"b21","series-title":"Nat Commun","first-page":"368","article-title":"Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands","volume":"10","author":"Haller F","year":"2019","unstructured":"Haller F, Bieg M, Will R,  Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun. 2019;10(1):368."}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/7\/11\/article-CASE2476.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/7\/11\/article-CASE2476.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/7\/11\/article-CASE2476.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:25:40Z","timestamp":1770301540000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/7\/11\/article-CASE2476.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":42,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.3171\/case2476","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}